Clofazimine as a drug for TB in the mouse model

Date:

January 29, 2015 at 12:15pm - 1:20pm

In this lecture, Dr. Jaques Grosset describes his effort to reproduce results of a multi-drug TB treatment regimen that utilized Clofazimine for treating patients with drug resistance, using the mouse model.

Video/Audio/Slides

Audio-only/Slides

Projects

The role of cell wall lipids in pathogenesis...

This study will use a combination of transcriptional, lipidomic, genetic, and imaging techniques to investigate whether...

Read More

TBM-KIDS (India)

A phase 2 clinical trial of optimized treatment for pediatric tuberculous meningitis in India and Malawi

Read More

Impact of diabetes on TB treatment outcomes...

This is a study to prospectively enroll and follow TB patients co-infected with diabetes and TB patients without diabetes...

Read More

Statins as adjunctive host-directed therapy...

This study will investigate the role of statins in combination with the first-line regimen for TB in the mouse model. In...

Read More